Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 12, 2005, Pages 2114-2119

  Glanville, Allan R ^a   Scott, Andrew I R ^a   Morton, Judith M ^a   Aboyoun, Christina L ^a   Plit, Marshall L ^a   Carter, Ian W ^b   Malouf, Monique A ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISOLONE; RIBAVIRIN; SULFAMETHIZOLE; TACROLIMUS; TRIMETHOPRIM;

ADULT; ANIMAL CELL; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; EMBRYO; EMPHYSEMA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; INFLUENZA; INFORMATION PROCESSING; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG INJURY; LUNG TRANSPLANTATION; MALE; MORTALITY; NASOPHARYNX; NONHUMAN; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SYMPTOM; THROAT CULTURE; TIME; VIRUS CULTURE; VIRUS IDENTIFICATION; VIRUS INFECTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 29144465115     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.06.027     Document Type: Article

References (33)

1. C.H. Wendt, J.M. Fox, M.I. Hertz Paramyxovirus infection in lung transplant recipients J Heart Lung Transplant 14 1995 479 485
2. R. Speich, W. van der Bij Epidemiology and management of infections after lung transplantation Clin Infect Dis 33 suppl 1 2001 S58 S65
3. T.N. Small, A. Casson, S.F. Malak Respiratory syncytial virus infection following hematopoietic stem cell transplantation Bone Marrow Transplant 29 2002 321 327
4. S. Krinzman, N. Basgoz, R. Kradin Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants J Heart Lung Transplant 17 1998 202 210
5. S.M. Palmer Jr, N.G. Henshaw, D.N. Howell, S.E. Miller, R.D. Davis, V.F. Tapson Community respiratory viral infection in adult lung transplant recipients Chest 113 1998 944 950
6. L.D. Matar, H.P. McAdams, S.M. Palmer Respiratory viral infections in lung transplant recipients radiologic findings with clinical correlation Radiology 213 1999 735 742
7. P.M. Hopkins, M.L. Plit, I.W. Carter, P.N. Chhajed, M.A. Malouf, A.R. Glanville Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients J Heart Lung Transplant 22 2003 161 168
8. A.R. Falsey, E.E. Walsh Respiratory syncytial virus infection in adults Clin Microbiol Rev 13 2000 371 384
9. J.B. Domachowske, H.F. Rosenberg Respiratory syncytial virus infection immune response, immunopathogenesis, and treatment Clin Microbiol Rev 12 1999 298 309
10. J.P. Ko, J.A. Shepard, M.W. Sproule CT manifestations of respiratory syncytial virus infection in lung transplant recipients J Comput Assist Tomogr 24 2000 235 241
11. E. Sparrelid, P. Ljungman, E. Ekelof-Andstrom Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections Bone Marrow Transplant 19 1997 905 908
12. J.L. Kimpen Management of respiratory syncytial virus infection Curr Opin Infect Dis 14 2001 323 328
13. J.D. Graci, C.E. Cameron Quasispecies, error catastrophe, and the antiviral activity of ribavirin Virology 298 2002 175 180
14. The IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102 1998 531 537
15. T.L. Gower, B.S. Graham Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro Antimicrob Agents Chemother 45 2001 1231 1237
16. M. Estenne, J.R. Maurer, A. Boehler Bronchiolitis obliterans syndrome 2001 an update of the diagnostic criteria J Heart Lung Transplant 21 2002 297 310
17. Diagnostics Division, Intracel Corp. Report on the Bartels Viral Respiratory Screening and Identification Kit. Publication 3450-0185E 1995 Intracel Issaquah, WA
18. E.H. Lennette, A. Balows, W.J. Hausler, H.J. Shadomy Manual of clinical microbiology 4th ed. 1995 American Society of Microbiology Washington, DC 687 693
19. J.M. Morton, C.L. Aboyoun, M.A. Malouf, M.L. Plit, A.R. Glanville Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation J Heart Lung Transplant 23 2004 1035 1039
20. A.R. Glanville, J.M. Morton, C.L. Aboyoun, M.L. Plit, M.A. Malouf Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation J Heart Lung Transplant 23 2004 1170 1174
21. A.P. Khalifah, R.R. Hachem, M.M. Chakinala Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death Am J Respir Crit Care Med 170 2004 181 187
22. J. Garbino, M.W. Gerbase, W. Wunderli Lower respiratory viral illnesses improved diagnosis by molecular methods and clinical impact Am J Respir Crit Care Med 170 2004 1197 1203
23. M.D. Allen, C.M. Burke, C.G. McGregor, J.C. Baldwin, S.W. Jamieson, J. Theodore Steroid-responsive bronchiolitis after human heart-lung transplantation J Thorac Cardiovasc Surg 92 1986 449 451
24. L.H. McCurdy, A. Milstone, S. Dummer Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin J Heart Lung Transplant 22 2003 745 753
25. J.R. Doud, T. Hinkamp, E.R. Garrity Jr Respiratory syncytial virus pneumonia in a lung transplant recipient case report J Heart Lung Transplant 11 1992 77 79
26. M. Murris-Espin, A. Didier, P. Carre, J. Icart, S. Henry, P. Leophonte Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients Lancet 341 1993 897
27. M. Schleuning, H. Buxbaum-Conradi, G. Jager, H.J. Kolb Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants Hematol J 5 2004 135 144
28. J.L. Billings, M.I. Hertz, C.H. Wendt Community respiratory virus infections following lung transplantation Transplant Infect Dis 3 2001 138 148
29. Swedish Consensus Group Management of infections caused by respiratory syncytial virus Scand J Infect Dis 33 2001 323 328
30. D.M. Lewinsohn, R.A. Bowden, D. Mattson, S.W. Crawford Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation Antimicrob Agents Chemother 40 1996 2555 2557
31. A.G. Randolph, E.E. Wang Ribavirin for respiratory syncytial virus infection of the lower respiratory tract Cochrane Database Syst Rev 2000 CD000181
32. C.A. Bonville, P.A. Mehta, L.R. Krilov, H.F. Rosenberg, J.B. Domachowske Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone Cell Immunol 213 2001 134 140
33. J.J. Wright, G. O'Driscoll Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone J Heart Lung Transplant 24 2005 343 346